Our Publications

Selected Publications

  1. Leung, AA, Nerenberg, K, Daskalopoulou, SS, McBrien, K, Zarnke, KB, Dasgupta, K et al.. Hypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2016;32 (5):569-88. doi: 10.1016/j.cjca.2016.02.066. PubMed PMID:27118291
  1. Gilbert, RE, Weir, MR, Fioretto, P, Law, G, Desai, M, Kline, I et al.. Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies. Can J Diabetes. 2016;40 (3):247-57. doi: 10.1016/j.jcjd.2015.11.005. PubMed PMID:27052454.
  1. Yuen, DA, Huang, YW, Liu, GY, Patel, S, Fang, F, Zhou, J et al.. Recombinant N-Terminal Slit2 Inhibits TGF-β-Induced Fibroblast Activation and Renal Fibrosis. J. Am. Soc. Nephrol. 2016. doi: 10.1681/ASN.2015040356. PubMed PMID:26869008.
  1. Gilbert, RE, Ruschitzka, F. Henry Krum, Pioneering Heart Failure Researcher. Eur. J. Heart Fail. 2016;18 (2):125-6. doi: 10.1002/ejhf.498. PubMed PMID:26861037
  1. Duarte, DA, Papadimitriou, A, Gilbert, RE, Thai, K, Zhang, Y, Rosales, MA et al.. Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes. PLoS ONE. 2016;11 (2):e0147978. Epub 2016/2/2. doi: 10.1371/journal.pone.0147978. PubMed PMID:26836609 PubMed Central PMC4737492.
  1. Zhang Y, Thai K, Kepecs DM, Gilbert RE. (2016). Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease. PLoS One.11(1): e0144640.
  1. Gilbert RE, Thai K, Advani SL, Cummins CL, Kepects DM,Schroer SA, Woo M, Zhang Y. (2015). Sirt1 activation ameliorates hyperglycaemia by inducing a torpor-like state in obese type 2 diabetic mice. Diabetologia. 58(4): 819-827.
  1. Connelly KA, Advani A, Zhang Y, Advani SL, Kabir G, Abadeh A, Desjardins J-F, Mitchell M, Thai K, Gilbert RE. (2015). Dipeptidyl peptidase-4inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α. J Diabetes. 2016 Jan;8(1):63-75.
  1. Gilbert RE, Connelly KA. (2015). Understanding EMPA-REG OUTCOME. Lancet Diabetes Endocrinol.3(12): 930-931.
  1. Gilbert RE. (2015). Heart failure: fatal, forgotten, and frequent in type 1 diabetes too. Lancet Diabetes and Endocrinology. 1: 1-2.
  1. Gilbert RE. (2015). Heart Failure in SAVOR-TIMI 53: The hindsight of diabetic retinopathy. Diabetes. 7(3): 304-306.
  1. Gilbert RE (Principal Author), Krum H.(2015). Heart Failure in Diabetes: Effects of anti-hyperglycaemic drug therapy. Lancet. 385(9982): 2107-2117.
  1. Gilbert RE. Sodium-glucose linked transporter-2 (SGLT2) inhibitors: Potential for renoprotection beyond blood glucose lowering. Invited Review. Kidney Int. 86(4): 693-700, 2014.
  1. Kosanam H, Thai K, Zhang Y, Advani A, Connelly KA, Diamandis EP, Gilbert RE. Diabetes induces lysine acetylation of the intermediary metabolism enzymes in the kidney. Diabetes. 63(7): 2432-2439, 2014
  1. Gilbert RE. The perils of clinical trials. Invited commentary. Kidney Int.85(4): 745-747, 2014.
  1. Gilbert RE. The perils of clinical trials. Kidney International. 85(4): 745-747, 2014
  1. Gilbert RE (Principal Author), Mann JF, Hanefeld M, Spinas G, BOsch J, Yusuf S, Gertein HC
and the ORIGIN Trial Investigators. Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: Results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial. Diabetologia. 57(7): 1325-1331, 2014.
  1. Gilbert RE. (2014). SGLT-2 inhibition in patients with kidney disease. Diab Metab. 40(6): S23-S27.
  1. Yuen DA, Connelly KA, Zhang Y, Advani S, Thai K, Kabir G, Kepecs D, Spring C, Smith C, Batruch I, Kosanam H, Avani A, Diamandis EP, Marsden PA, Gilbert RE (Senior Author).(2013). Early outgrowth cells release soluble endocrine anti-fibrotic factors that reduce progressive organ fibrosis. Stem Cells. 31(11): 2408-2419.
  1. Connelly KA, Advani A, Zhang Y, Advani SL, Kabir G, Abadeh A, Desjardins JF, Mitchell M, Thai K, Gilbert RE. (2013). Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1 a hypothesis. J Diabetes. 5(3): 258-260.
  1. Zhang Y, Yuen DA, Advani A, Thai K, Advani SL, Kepecs D, Kabir MG, Connelly KA, Gilbert RE (Senior Author).(2012). Early out-growth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes. Diabetes. 61(8): 2114-2125.
  1. Advani A, Connelly KA, Yuen DA, Zhang Y, Advani SL, Trogadis, J, Kabir MG, Shachar E, Kuliszewski MA, Leong-Poi H, Stewart DJ, Gilbert RE (2011). Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculature. PloS One. 6(10): e24695.
  1. Gilbert RE (Principal Author), Huang Q, Thai K, Advani SL, Lee K, Yuen DA, Connelly KA, Advani A. (2011). Histone deacetylase inhibition attenuates diabetes associated kidney growth: Potential role for epigenetic modification of the epidermal growth factor receptor. Kidney International. 79(12): 1312-1321.
  1. Advani A, Huang Q, Thai K, Advani SL, White KE, Gilbert RE (Senior Author).(2011). Long term administration of the Histone Deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.Am J Pathol. 178(5): 2205-2214. 
Last Author Published Refereed?: Yes
  1. Tokuyama H, Kim S, Zhang Y, Langham RG, Cox AJ, Gow RM, Kelly DJ, Gilbert RE (Senior Author).(2011). Protein kinase C B inhibition ameliorates experimental mesangial proliferative glomerulonephritis.Nephrology. 16(7): 649-655.
Last Author 
Published Refereed?: Yes
  1. Campbell DJ, Zhang Y, Kelly DJ, Gilbert RE, McCarthy DJ, Shi W, Smyth GK.(2011). Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.Clin Exp Pharmacol Physiol. 38(9): 623-631. Co-Author
Refereed?: Yes